Marshall Wace, LLP Augmedix, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Augmedix, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 338,445 shares of AUGX stock, worth $297,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
338,445
Previous 43,725
674.03%
Holding current value
$297,831
Previous $255,000
442.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AUGX
# of Institutions
97Shares Held
44.1MCall Options Held
491KPut Options Held
445K-
Redmile Group, LLC San Francisco, CA16.4MShares$14.4 Million2.64% of portfolio
-
Dcm International Vi, Ltd.4.17MShares$3.67 Million5.31% of portfolio
-
Samjo Capital LLC2.91MShares$2.56 Million5.93% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.89MShares$1.66 Million0.0% of portfolio
-
Perkins Capital Management Inc1.46MShares$1.28 Million5.15% of portfolio
About Augmedix, Inc.
- Ticker AUGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,421,200
- Market Cap $32.9M
- Description
- Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...